SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Crinetics Pharmaceuticals, Inc.
@CRNX_InsiderForm 4 Filing: Okey Stephanie Acquires (Grant) shares of $CRNX
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Crinetics Pharmaceuticals, Inc.
Ticker: $CRNX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-18
Shares: 5,925
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Okey Stephanie, holds the title of Director at Crinetics Pharmaceuticals, Inc..
On 2026-06-18, the insider transacted 5,925 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Okey Stephanie (Director) was granted $0 of $CRNX
Post-Transaction Position: 12,325 shares
SEC Accession No: 0001628280-26-044708 (CIK: 1742616)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.